The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas

European Journal of Cancer

Volumn 35, Issue 8, 1999, Pages 1264-1267

  Sarela, A I ^a   Farmery, S M ^a   Markham, A F ^b   Guillou, P J ^a  

^a Level 8 Clin Sci Bldg St J   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chromosome deletion; Colorectal neoplasms; Gene deletion; Loss of heterozygosity; Mutation; Polymerase chain reaction; Polymorphism; Single stranded conformational

Indexed keywords

ARTICLE; CHROMOSOME DELETION; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSS OF HETEROZYGOSITY; MUTATION; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032774086     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00104-5     Document Type: Article

References (18)

1. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
2. ING1 promotes neoplastic transformation. Nature Genet. 14:1996;415-420.
3. Helbing C.C., Veillette C., Riabowol K., Johnston R.N., Garkavtsev I. A novel candidate tumour supppressor, ING1, involved in regulation of apoptosis. Cancer Res. 57:1997;1255-1258.
4. ING1 cooperates with p53 in cell growth control. Nature. 391:1998;295-298.
5. Garkavtsev I., Demetrick D., Riabowol K. Cellular localization and chromosome mapping of a novel candidate tumour suppressor gene (ING1). Cytogenet. Cell Genet. 76:1997;176-178.
6. Motomura K., Nishisho I., Takai S.et al. Loss of alleles at loci on chromosome 13 in human primary gastric cancers. Genomics. 2:1988;180-184.
7. Maestro R., Paccinin S., Doglioni C.et al. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas. identification of two distinct regions of preferential loss Cancer Res. 56:1996;1146-1150.
8. Oren M. Tumour suppressors. Teaming up to restrain cancer. Nature. 391:1998;233-234.
9. Dib C., Faure S., Fizames C.et al. A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature. 380:1996;152-154.
10. White R.L. Tumor suppressing pathways. Cell. 92:1998;591-592.
11. Scott N., Quirke P. Molecular biology of colorectal neoplasia. Gut. 34:1993;289-292.
12. Skuse G.R., Ludlow J.W. Tumour suppressor genes in disease and therapy. Lancet. 345:1995;902-906.
13. Lothe R.A., Peltomaki P., Meling G.I.et al. Genomic instability in colorectal cancer. relationship to clinicopathological variables and family history Cancer Res. 53:1993;5849-5852.
14. Senba S., Konishi F., Okamoto T.et al. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors. Cancer. 82:1998;279-285.
15. Matsuda Y., Ichida T., Matsuzawa J., Sugimura K., Asakura H. p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology. 116:1999;394-400.
16. Graff J.R., Herman J.G., Lapidus R.G.et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55:1995;5195-5199.
17. Dobrovic A., Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57:1997;3347-3350.
18. Ahuja N., Li Q., Mohan A.L., Baylin S.B., Issa J.P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 58:1998;5489-5494.